why choose us

Clinical Trials Search

Showing 15,570 of 132,656 result(s)
Characterization of Natural IL-6 Inhibition in Healthy Individuals

Status: Completed

Condition: Autoantibodies

Interventions: 75g oral glucose tolerance test, sampled over three hours

Date: 2023-01-27

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

Status: ACTIVE_NOT_RECRUITING

Condition: Metastatic Non-small Cell Lung Cancer

Interventions: MK3475A SC will be administered for squamous and nonsquamous NSCLC as per the schedule specified in arm; participants may be eligible for second cours

Date: 2023-01-27

Remote Tai Ji for Low Back Pain

Status: Completed

Condition: Low Back Pain

Interventions: T'ai chi;Qigong is a multidimensional (mind, body, and spirit integrative) and multimodal (strength, flexibility, balance, posture, and ligh

Date: 2023-01-27

Mepivacaine vs. Bupivacaine Spinal for TKA

Status: Completed

Condition: Total Knee Replacement

Interventions: spinal block using 60mg of mepivacaine

Date: 2023-01-27

Shockwave, Photobiomodulation, and Physical Therapy for Achilles Tendinopathy

Status: Completed

Condition: Achilles Tendinopathy

Interventions: All participants may complete a PT program as standard of care (SOC) treatment addressing individual strength, mobility, and flexibility deficits in b

Date: 2023-01-27

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Status: Completed

Condition: Depression

Interventions: Injected IV followed by PET scanning

Date: 2023-01-27

Intervention for Fatigue in HCT Recipients

Status: NOT_YET_RECRUITING

Condition: Hematologic Cancer

Interventions: 10, individualized counseling sessions with a behavioral health counselor via Zoom platform.

Date: 2023-01-27

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Status: Completed

Condition: Rotator Cuff Tendinopathy

Interventions: The participants will receive Secukinumab 300 mg s.c. at randomization (Baseline visit), Week 1, 2, 3, 4, 8, and 12

Date: 2023-01-27

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Status: Completed

Condition: Solid Tumor

Interventions: SAIL66 as a IV infusion

Date: 2023-01-27